HEADER TRANSFERASE 26-MAY-17 5O49 TITLE HUMAN FGF IN COMPLEX WITH A COVALENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 5 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FGFR FIBROBLAST GROWTH FACTOR, COVALENT INHIBITION, FGFR FIBROBLAST KEYWDS 2 GRWTH FCTR RTK, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.DEBRECZENI,J.BREED,H.MUKHERJEE,B.AQUILA,C.KAISER,S.TENTARELLI, AUTHOR 2 A.WHITTY,N.GRIMSTER REVDAT 1 07-FEB-18 5O49 0 JRNL AUTH H.MUKHERJEE,J.DEBRECZENI,J.BREED,S.TENTARELLI,B.AQUILA, JRNL AUTH 2 J.E.DOWLING,A.WHITTY,N.P.GRIMSTER JRNL TITL A STUDY OF THE REACTIVITY OF S(VI)-F CONTAINING WARHEADS JRNL TITL 2 WITH NUCLEOPHILIC AMINO-ACID SIDE CHAINS UNDER PHYSIOLOGICAL JRNL TITL 3 CONDITIONS. JRNL REF ORG. BIOMOL. CHEM. V. 15 9685 2017 JRNL REFN ESSN 1477-0539 JRNL PMID 29119993 JRNL DOI 10.1039/C7OB02028G REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 57008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4308 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 131 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5O49 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200005156. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57050 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 49.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.03600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.73500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-20% (W/V) PEG8000, 200MM AMMONIUM REMARK 280 SULPHATE, 100MM PCTP PH 6.75 AND 20% (V/V) ETHYLENE GLYCOL, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.77500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.79500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.77500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.79500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 765 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 GLU A 467 CG CD OE1 OE2 REMARK 470 LYS A 482 CG CD CE NZ REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 PHE A 489 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 ASP A 501 CG OD1 OD2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 LYS A 504 CG CD CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 516 CG CD1 CD2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 SER A 518 OG REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 LYS A 542 CD CE NZ REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 GLN A 594 CG CD OE1 NE2 REMARK 470 ARG A 646 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 647 CG OD1 OD2 REMARK 470 ILE A 648 CG1 CG2 CD1 REMARK 470 HIS A 649 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 650 CG ND1 CD2 CE1 NE2 REMARK 470 ILE A 651 CG1 CG2 CD1 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 THR A 658 OG1 CG2 REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CE NZ REMARK 470 ASP A 720 CG OD1 OD2 REMARK 470 ASN A 724 CG OD1 ND2 REMARK 470 MET A 731 CG SD CE REMARK 470 LYS A 748 CD CE NZ REMARK 470 GLU A 752 CG CD OE1 OE2 REMARK 470 VAL B 460 CG1 CG2 REMARK 470 SER B 461 OG REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 464 CG CD OE1 OE2 REMARK 470 GLU B 467 CG CD OE1 OE2 REMARK 470 ASP B 476 CG OD1 OD2 REMARK 470 VAL B 479 CG1 CG2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 496 CG CD OE1 OE2 REMARK 470 ILE B 498 CG1 CG2 CD1 REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 510 CD CE NZ REMARK 470 LYS B 517 CE NZ REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 LYS B 523 CD CE NZ REMARK 470 GLU B 593 CG CD OE1 OE2 REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LEU B 595 CG CD1 CD2 REMARK 470 LYS B 618 CE NZ REMARK 470 GLU B 633 CG CD OE1 OE2 REMARK 470 ASP B 641 CG OD1 OD2 REMARK 470 LEU B 644 CG CD1 CD2 REMARK 470 HIS B 650 CG ND1 CD2 CE1 NE2 REMARK 470 ILE B 651 CG1 CG2 CD1 REMARK 470 LYS B 655 CG CD CE NZ REMARK 470 LYS B 656 CG CD CE NZ REMARK 470 LEU B 672 CG CD1 CD2 REMARK 470 ASP B 674 CG OD1 OD2 REMARK 470 GLU B 707 CG CD OE1 OE2 REMARK 470 LYS B 714 CE NZ REMARK 470 ASP B 720 CG OD1 OD2 REMARK 470 ASN B 724 CG OD1 ND2 REMARK 470 GLU B 728 CG CD OE1 OE2 REMARK 470 MET B 731 CG SD CE REMARK 470 GLN B 743 CG CD OE1 NE2 REMARK 470 LYS B 748 CG CD CE NZ REMARK 470 GLU B 752 CG CD OE1 OE2 REMARK 470 ASN B 763 CG OD1 ND2 REMARK 470 GLN B 764 CG CD OE1 NE2 REMARK 470 GLU B 765 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 670 CD GLU A 670 OE1 0.085 REMARK 500 PRO B 741 CD PRO B 741 N -0.097 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 682 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 517 171.92 -54.82 REMARK 500 ARG A 622 -6.18 76.28 REMARK 500 ASP A 623 48.15 -152.20 REMARK 500 HIS A 649 -0.54 88.13 REMARK 500 SER B 461 -2.30 -56.50 REMARK 500 ARG B 622 -5.93 75.62 REMARK 500 ASP B 623 60.88 -152.54 REMARK 500 CYS B 725 125.07 -170.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9K5 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 9K5 B 801 and LYS B REMARK 800 514 DBREF 5O49 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 5O49 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 5O49 GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 5O49 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 5O49 SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 5O49 GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 5O49 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 5O49 SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET 9K5 A 801 30 HET SO4 A 802 5 HET SO4 A 803 5 HET 9K5 B 801 30 HET SO4 B 802 5 HETNAM 9K5 [(2~{R},3~{S},4~{R},5~{R})-5-(6-AMINOPURIN-9-YL)-3,4- HETNAM 2 9K5 BIS(OXIDANYL)OXOLAN-2-YL]METHYL 3- HETNAM 3 9K5 FLUOROSULFONYLBENZOATE HETNAM SO4 SULFATE ION FORMUL 3 9K5 2(C17 H16 F N5 O7 S) FORMUL 4 SO4 3(O4 S 2-) FORMUL 8 HOH *131(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 LEU A 662 MET A 667 5 6 HELIX 7 AA7 ALA A 668 ARG A 675 1 8 HELIX 8 AA8 THR A 678 THR A 695 1 18 HELIX 9 AA9 PRO A 705 GLU A 715 1 11 HELIX 10 AB1 THR A 726 TRP A 737 1 12 HELIX 11 AB2 VAL A 740 ARG A 744 5 5 HELIX 12 AB3 THR A 746 THR A 761 1 16 HELIX 13 AB4 PRO B 474 ASP B 476 5 3 HELIX 14 AB5 THR B 521 GLY B 539 1 19 HELIX 15 AB6 ASN B 568 ALA B 575 1 8 HELIX 16 AB7 SER B 596 LYS B 617 1 22 HELIX 17 AB8 ALA B 625 ARG B 627 5 3 HELIX 18 AB9 LEU B 662 MET B 667 5 6 HELIX 19 AC1 ALA B 668 ARG B 675 1 8 HELIX 20 AC2 THR B 678 THR B 695 1 18 HELIX 21 AC3 PRO B 705 GLU B 715 1 11 HELIX 22 AC4 THR B 726 TRP B 737 1 12 HELIX 23 AC5 VAL B 740 ARG B 744 5 5 HELIX 24 AC6 THR B 746 LEU B 760 1 15 SHEET 1 AA1 5 LEU A 478 GLU A 486 0 SHEET 2 AA1 5 GLY A 490 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA1 5 VAL A 508 LEU A 516 -1 O VAL A 513 N VAL A 493 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLU B 486 0 SHEET 2 AA3 5 GLY B 490 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 AA3 5 VAL B 508 LEU B 516 -1 O VAL B 513 N VAL B 493 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N GLY B 549 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 LINK NZ LYS A 514 S 9K5 A 801 1555 1555 1.68 LINK NZ LYS B 514 S 9K5 B 801 1555 1555 1.72 SITE 1 AC1 16 LEU A 484 GLY A 485 GLU A 486 GLY A 487 SITE 2 AC1 16 PHE A 489 GLY A 490 VAL A 492 ALA A 512 SITE 3 AC1 16 LYS A 514 VAL A 561 GLU A 562 TYR A 563 SITE 4 AC1 16 ALA A 564 LEU A 630 ASP A 641 HOH A 910 SITE 1 AC2 7 ARG A 570 ARG A 627 THR A 657 ASN A 659 SITE 2 AC2 7 ARG A 661 TRP A 666 HOH A 904 SITE 1 AC3 4 GLY A 539 LYS A 540 LYS A 618 HOH A 933 SITE 1 AC4 6 ARG B 570 ARG B 627 THR B 657 ASN B 659 SITE 2 AC4 6 ARG B 661 HOH B 901 SITE 1 AC5 21 LEU B 484 GLY B 485 GLU B 486 PHE B 489 SITE 2 AC5 21 GLN B 491 VAL B 492 ALA B 512 VAL B 513 SITE 3 AC5 21 MET B 515 LEU B 528 GLU B 531 TYR B 558 SITE 4 AC5 21 VAL B 559 GLU B 562 TYR B 563 ALA B 564 SITE 5 AC5 21 LEU B 630 HOH B 904 HOH B 912 HOH B 926 SITE 6 AC5 21 HOH B 933 CRYST1 209.550 57.590 65.620 90.00 107.64 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004772 0.000000 0.001517 0.00000 SCALE2 0.000000 0.017364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015991 0.00000